BCM
AMPE

Bridgeway Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bridgeway Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,023
Closed -$37K – 1508
2022
Q3 		$37K Hold
2,023
– – ﹤0.01% 1365
2022
Q2 		$102K Hold
2,023
– – ﹤0.01% 1220
2022
Q1 		$285K Sell
2,023
-570
-22% -$83.3K 0.01% 1093
2021
Q4 		$443K Sell
2,593
-396
-13% -$148K 0.01% 1016
2021
Q3 		$1.49M Sell
2,989
-417
-12% -$193K 0.03% 712
2021
Q2 		$1.71M Sell
3,406
-330
-9% -$177K 0.03% 683
2021
Q1 		$1.89M Hold
3,736
– – 0.04% 639
2020
Q4 		$1.78M Sell
3,736
-166
-4% -$54.5K 0.04% 560
2020
Q3 		$1.12M Hold
3,902
– – 0.03% 637
2020
Q2 		$746K Buy
+3,902
New +$649K 0.02% 742
2018
Q4 		– Sell
-333
Closed -$51K – 1496
2018
Q3 		$51K Hold
333
– – ﹤0.01% 1410
2018
Q2 		$220K Buy
+333
New +$249K ﹤0.01% 1298
2017
Q1 		– Sell
-183
Closed -$49K – 1491
2016
Q4 		$49K Hold
183
– – ﹤0.01% 1382
2016
Q3 		$41K Sell
183
-911
-83% -$255K ﹤0.01% 1405
2016
Q2 		$424K Buy
1,094
+150
+16% +$164K 0.01% 1114
2016
Q1 		$637K Buy
944
+588
+165% +$396K 0.01% 947
2015
Q4 		$374K Hold
356
– – 0.01% 1147
2015
Q3 		$309K Hold
356
– – 0.01% 1208
2015
Q2 		$253K Hold
356
– – 0.01% 1299
2015
Q1 		$804K Hold
356
– – 0.02% 884
2014
Q4 		$366K Sell
356
-94
-21% -$100K 0.01% 1170
2014
Q3 		$477K Hold
450
– – 0.01% 1093
2014
Q2 		$1.13M Buy
450
+150
+50% +$306K 0.03% 724
2014
Q1 		$572K Sell
300
-2
-0.7% -$4.73K 0.02% 1012
2013
Q4 		$647K Buy
302
+2
+0.7% +$4.73K 0.02% 920
2013
Q3 		$675K Buy
+300
New +$580K 0.02% 889

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Bridgeway Capital Management's AMPE Position: Q4 2022 in Review

Bridgeway Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 2,023 shares — an estimated $37K sold.

Bridgeway Capital Management first reported a position in AMPE in Q3 2013 and held it in 26 quarters. The position peaked at $1.89M in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Bridgeway Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 2,023 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $37K.
  • Bridgeway Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 26 quarters.
  • Bridgeway Capital Management's Ampio Pharmaceuticals Inc. position peaked at $1.89M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.